Precision BioSciences Inc.
DTIL | NASDAQ
$6.97
+$0.47 (+7.23%)
Sep 22, 2026, 1:47 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -1.17 | 3.63 | -0.69 | -0.94 | -14.23 | -3.98 |
PEG Ratio | 0 | -0.03 | 0.01 | -0.01 | 0.19 | -0.71 |
PS Ratio | 1.56 | 0.38 | 0.86 | 4.17 | 3.76 | 17.87 |
PB Ratio | 0.58 | 0.46 | 2.23 | 1.73 | 4.76 | 9.77 |
P/FCF Ratio | -0.81 | -0.44 | -0.49 | -2.13 | -26.07 | -4.70 |
P/OCF Ratio | -0.81 | -0.45 | -0.50 | -2.29 | -40.02 | -4.97 |
OCF/S Ratio | -192.16 | -85.08 | -172.62 | -182.30 | -9.39 | -359.84 |
Debt / Equity Ratio | 0.31 | 0.53 | 1.66 | 0.41 | 0.10 | 0.24 |
Quick Ratio | 13.32 | 6.34 | 2.73 | 3.34 | 4.50 | 2.46 |
Current Ratio | 13.32 | 6.34 | 2.73 | 3.34 | 4.50 | 2.46 |
Asset Turnover | 0.22 | 0.50 | 0.30 | 0.11 | 0.55 | 0.16 |
Interest Coverage | -36.67 | -14.68 | -19.61 | -56.08 | -298.30 | n/a |
Return on Equity | -49.57% | 12.71% | -325.11% | -184.73% | -33.57% | -245.37% |
Return on Assets | -29.61% | 5.25% | -38.38% | -46.87% | -14.47% | -72.59% |
Return on Invested Capital | -35.47% | -21.32% | -32.80% | -34.58% | -22.20% | -100.52% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 100% | 100% | 100% |
Net Profit Margin | -133.45% | 10.43% | -125.84% | -444.80% | -26.49% | -448.86% |
Pretax Profit Margin | -136.03% | 10.43% | -87.28% | -290.50% | -26.49% | -448.86% |
Operating Profit Margin | -152.19% | -38.08% | -89.76% | -248.26% | -34.08% | -452.25% |
FCF Margin | -192.41% | -85.44% | -177.30% | -195.52% | -14.42% | -380.55% |
EBITDA Margin | -123.84% | 19.69% | -65.76% | -250.20% | -17.55% | -408.45% |
Add to Watchlist
Select watchlists to add or remove DTIL